Pandemic Disruptions Worsened Cancer Survival, Study Finds

Research shows COVID-19 delays led to more cancer deaths in the short term.

Published on Feb. 7, 2026

Got story updates? Submit your updates here. ›

A new study suggests that pandemic-related disruptions to cancer diagnosis and treatment during the early years of COVID-19 led to worsened short-term survival rates for cancer patients. The study is the first to directly assess the impact of these pandemic-era healthcare disruptions on cancer outcomes.

Why it matters

The findings underscore the significant public health consequences of the pandemic's strain on the healthcare system, which led to delayed cancer screenings, postponed treatments, and other disruptions that impacted patient outcomes. This study provides evidence of the downstream effects of the pandemic on non-COVID health issues.

The details

The study analyzed data on cancer patients diagnosed before and during the pandemic, finding that those diagnosed after the onset of COVID-19 had lower short-term survival rates compared to those diagnosed earlier. Researchers attribute this to pandemic-related delays in cancer screenings, diagnoses, and treatments that prevented timely interventions.

  • The study analyzed data on cancer patients diagnosed before and during the COVID-19 pandemic.

The players

COVID-19 pandemic

The global health crisis caused by the novel coronavirus that began in 2020.

Got photos? Submit your photos here. ›

The takeaway

This study highlights the significant public health consequences of the pandemic's strain on the healthcare system, underscoring the need to strengthen cancer screening, diagnosis, and treatment infrastructure to mitigate the impact of future health crises on non-COVID medical issues.